Archives

Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Tag: Gilead

COVID-19’s Impact on Biopharma Mergers & Acquisitions in 2020

COVID-19’s Impact on Biopharma Mergers & Acquisitions in 2020

Most reports indicate that 2020 was not a particularly good year for mergers and acquisitions (M&As) in the biopharma industry.  There’s also some disagreement on numbers which can be related to how they are defining sectors; healthcare versus biotech and pharmaceutical, for example.  Here’s a

Read More »

CORONAVIRUSES – ANTIVIRAL DRUG IN THE WORKS

Coronaviruses are responsible for 30% of human common colds.  More seriously they are responsible for SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory System).  In just over a decade, both SARS and MERS are two brand new viruses that have arisen from coronavirus. 

Read More »